SGLT2 Inhibitor Adds Years of Life to Patients With Heart Failure DAPA-HF group makes projections as long-term data are lacking Jul 28, 2021
Changes in Epicardial Fat May Drive SGLT2 Inhibitor Benefits More insight into mechanisms behind empagliflozin's cardioprotection Jul 26, 2021
Doubling Semaglutide Dose Helps Get HbA1c Under Control But when is it time to add another agent to the mix? Jul 22, 2021
Spinal Cord Stimulation OK'd for Diabetic Nerve Pain First device of its kind to gain FDA approval for painful diabetic neuropathy Jul 19, 2021
Dexcom's CGM Interoperability Expands; Warfarin and Osteoporosis; Maine Bans PFAS News and commentary from the endocrinology world Jul 18, 2021
Academic Cardiologists Singled Out for Gender Equality Problem Women still poorly represented, paid in procedural internal medicine specialties Jul 12, 2021
Walmart's Low-Price Insulin Is a Band-Aid on a Broken System Exorbitant drug pricing and inaccessible care require government intervention Jul 11, 2021
Finerenone OK'd for Slowing Kidney Disease in T2D Drug also indicated for cardiovascular event risk reduction Jul 09, 2021
CDC Study: Income-Related Inequalities Widening in Diabetes Disparities differed by sex and age group Jul 01, 2021
ADA 2021 Roundup: SoliMix Trial; Byetta for Teens; Driving in Hypoglycemia Noteworthy research from the American Diabetes Association virtual meeting Jun 30, 2021
Genetics, Socioeconomic Factors Each Tied to Diabetes and Obesity People with highest risk genetics more than 15 times more likely to have T2D Jun 30, 2021
Liraglutide and Insulin Come Out on Top for Glycemic Control in GRADE study Head-to-head comparison could help individualize treatment Jun 29, 2021
Resmetirom Delivers Promising Outcomes in NASH Without Invasive Follow-Up Real-world study also identifies noninvasive markers for treatment response Jun 29, 2021
Investigational GLP-1 RA Cuts Heart, Renal Risk in Vulnerable Diabetes Patients Exendin-4-based drug succeeded in cardiovascular outcomes trial Jun 28, 2021
180-Day Continuous Glucose Monitor Shows Promise in Adults With Diabetes Implantable Eversense system demonstrates accuracy in prospective study Jun 28, 2021
Hospitalization Rates for New-Onset Type 2 Diabetes in Kids Took Off During Pandemic "COVID-19 disrupted our lives in more ways than we realize" Jun 26, 2021
Combo GIP/GLP-1 Drug Superior for HbA1c Reduction in T2D 40-week trial compared tirzepatide head-to-head with injectable semaglutide Jun 25, 2021
'Modest' Erectile Dysfunction Benefit With GLP-1 Agonist Dulaglutide didn't improve pre-existing symptoms, but did prevent some new cases Jun 23, 2021
Best Pediatric Endocrinology Hospitals; Standards of Diabetes Care Updated News and commentary from the endocrinology world Jun 20, 2021
What Leads to Patients With Diabetes Relapsing After Bariatric Surgery? Risk factors included longer diabetes duration, higher preop HbA1c in Swedish study Jun 14, 2021
Nearly a Five-Fold Difference Between States in Use of Bariatric Surgery Weight loss procedure underutilized in areas with highest obesity prevalence Jun 13, 2021
Patients with Class I Obesity Still Benefit from Weight-Loss Surgery It may be time to update NIH-established indications for bariatric surgery, experts say Jun 12, 2021
Diabetic Man With Sclerosing Mesenteritis Experiences Glycemic Control With Steroids Case authors report an unexpected paradoxical effect Jun 07, 2021
Heart Risk With Gender-Affirming Tx; Burden of Thyroid Eye Disease; T1D Care Gaps More notable research from the AACE 2021 virtual meeting Jun 01, 2021
High Frequency Spinal Stimulation Succeeds in Diabetic Neuropathy Pain relief was significant and durable in SENZA-PDN trial May 29, 2021
COVID-19 in Diabetes: What Mediates Risk? Certain clinical factors tied to higher chance of severe infection May 28, 2021
Op-Ed: Let's Stop Equating Female and Male Bodies Medical tech needs to account for how gender agnostic conditions affect women differently May 27, 2021
Getting Competitive Boosted Physical Activity in Diabetes Competing for top spot increased mean daily step counts in gamified study May 24, 2021
Op-Ed: Diabetes Is Not an Equal Opportunity Killer Policy change and community intervention can help fight disparities May 23, 2021
FDA Draft Guidance on T2D Devices; New GLP-1 Drug Succeeds in Trial News and commentary from the endocrinology world May 23, 2021
Finerenone May Delay AFib Onset in Patients With CKD and Diabetes Risk of kidney or CV events reduced regardless of atrial fibrillation or atrial flutter history May 18, 2021
Adding GLP-1 Drug Makes Sleeve Gastroplasty a Diabetes Treatment Endoscopic procedure could yield benefits now seen only with more invasive surgery May 14, 2021
Amylin Analogue Plus Semaglutide Get Early Win for Weight Loss Combining agents yielded greater weight changes than semaglutide alone May 13, 2021
Post-Vax Adverse Events; Blood Groups and Disease: It's TTHealthWatch! Also this week: nanoparticle vaccine for COVID and dexamethasone for surgical site infections May 08, 2021 podcast
Saxenda Boosted Weight Loss, Especially With Exercise But year-long RCT excluded those with type 2 diabetes May 05, 2021
'Dancing With the Stars' Judge Carrie Ann Inaba's Autoimmune Diseases TV host takes leave of absence May 04, 2021
Farxiga Gets FDA Greenlight for CKD SGLT2 OK'd to prevent chronic kidney disease progression and cardiovascular risks Apr 30, 2021
Diabetes, Dementia, and Age: What's the Link? Age of diabetes onset, as well as cardiovascular comorbidities, play large role in dementia risk Apr 27, 2021
NKF 2021: Skewed Transplant Waitlists; Daft Diabetes Care Other noteworthy research presented at the National Kidney Foundation's annual meeting Apr 12, 2021
Pegloticase Safe for Dialysis Patients With Gout Significant drop in monthly ESA dose seen after treatment, too Apr 09, 2021
